228 related articles for article (PubMed ID: 26277094)
1. Behavioral signs of pain and functional impairment in a mouse model of osteogenesis imperfecta.
Abdelaziz DM; Abdullah S; Magnussen C; Ribeiro-da-Silva A; Komarova SV; Rauch F; Stone LS
Bone; 2015 Dec; 81():400-406. PubMed ID: 26277094
[TBL] [Abstract][Full Text] [Related]
2. Craniofacial and Dental Defects in the Col1a1Jrt/+ Mouse Model of Osteogenesis Imperfecta.
Eimar H; Tamimi F; Retrouvey JM; Rauch F; Aubin JE; McKee MD
J Dent Res; 2016 Jul; 95(7):761-8. PubMed ID: 26951553
[TBL] [Abstract][Full Text] [Related]
3. Correlations Between Bone Mechanical Properties and Bone Composition Parameters in Mouse Models of Dominant and Recessive Osteogenesis Imperfecta and the Response to Anti-TGF-β Treatment.
Bi X; Grafe I; Ding H; Flores R; Munivez E; Jiang MM; Dawson B; Lee B; Ambrose CG
J Bone Miner Res; 2017 Feb; 32(2):347-359. PubMed ID: 27649409
[TBL] [Abstract][Full Text] [Related]
4. Tendon properties in a mouse model of severe osteogenesis imperfecta.
Sinkam L; Boraschi-Diaz I; Svensson RB; Kjaer M; Komarova SV; Bergeron R; Rauch F; Veilleux LN
Connect Tissue Res; 2023 May; 64(3):285-293. PubMed ID: 36576243
[TBL] [Abstract][Full Text] [Related]
5. Metabolic phenotype in the mouse model of osteogenesis imperfecta.
Boraschi-Diaz I; Tauer JT; El-Rifai O; Guillemette D; Lefebvre G; Rauch F; Ferron M; Komarova SV
J Endocrinol; 2017 Sep; 234(3):279-289. PubMed ID: 28716975
[TBL] [Abstract][Full Text] [Related]
6. Sclerostin-Antibody Treatment Decreases Fracture Rates in Axial Skeleton and Improves the Skeletal Phenotype in Growing oim/oim Mice.
Cardinal M; Dessain A; Roels T; Lafont S; Ominsky MS; Devogelaer JP; Chappard D; Mabilleau G; Ammann P; Nyssen-Behets C; Manicourt DH
Calcif Tissue Int; 2020 May; 106(5):494-508. PubMed ID: 32025752
[TBL] [Abstract][Full Text] [Related]
7. Enhanced Wnt signaling improves bone mass and strength, but not brittleness, in the Col1a1(+/mov13) mouse model of type I Osteogenesis Imperfecta.
Jacobsen CM; Schwartz MA; Roberts HJ; Lim KE; Spevak L; Boskey AL; Zurakowski D; Robling AG; Warman ML
Bone; 2016 Sep; 90():127-32. PubMed ID: 27297606
[TBL] [Abstract][Full Text] [Related]
8. Effect of sclerostin antibody treatment in a mouse model of severe osteogenesis imperfecta.
Roschger A; Roschger P; Keplingter P; Klaushofer K; Abdullah S; Kneissel M; Rauch F
Bone; 2014 Sep; 66():182-8. PubMed ID: 24953712
[TBL] [Abstract][Full Text] [Related]
9. Skeletal phenotypes in adult patients with osteogenesis imperfecta-correlations with COL1A1/COL1A2 genotype and collagen structure.
Hald JD; Folkestad L; Harsløf T; Lund AM; Duno M; Jensen JB; Neghabat S; Brixen K; Langdahl B
Osteoporos Int; 2016 Nov; 27(11):3331-3341. PubMed ID: 27256333
[TBL] [Abstract][Full Text] [Related]
10. Does the Skeletal Phenotype of Osteogenesis Imperfecta Differ for Patients With Non-COL1A1/2 Mutations? A Retrospective Study in 113 Patients.
Zerfu T; Yong B; Harrington J; Howard A
J Pediatr Orthop; 2022 May-Jun 01; 42(5):e507-e514. PubMed ID: 35200215
[TBL] [Abstract][Full Text] [Related]
11. First mouse model for combined osteogenesis imperfecta and Ehlers-Danlos syndrome.
Chen F; Guo R; Itoh S; Moreno L; Rosenthal E; Zappitelli T; Zirngibl RA; Flenniken A; Cole W; Grynpas M; Osborne LR; Vogel W; Adamson L; Rossant J; Aubin JE
J Bone Miner Res; 2014 Jun; 29(6):1412-23. PubMed ID: 24443344
[TBL] [Abstract][Full Text] [Related]
12. Effect of Anti-TGF-β Treatment in a Mouse Model of Severe Osteogenesis Imperfecta.
Tauer JT; Abdullah S; Rauch F
J Bone Miner Res; 2019 Feb; 34(2):207-214. PubMed ID: 30357929
[TBL] [Abstract][Full Text] [Related]
13. Osteogenesis imperfecta in children and adolescents-new developments in diagnosis and treatment.
Trejo P; Rauch F
Osteoporos Int; 2016 Dec; 27(12):3427-3437. PubMed ID: 27492436
[TBL] [Abstract][Full Text] [Related]
14. Novel ActRIIB ligand trap increases muscle mass and improves bone geometry in a mouse model of severe osteogenesis imperfecta.
Tauer JT; Rauch F
Bone; 2019 Nov; 128():115036. PubMed ID: 31419601
[TBL] [Abstract][Full Text] [Related]
15. Muscle-bone properties after prolonged voluntary wheel running in a mouse model of dominant severe osteogenesis imperfecta.
Tauer JT; Rigo Canevazzi GH; Schiettekatte-Maltais J; Rauch F; Bergeron R; Veilleux LN
J Musculoskelet Neuronal Interact; 2021 Dec; 21(4):517-527. PubMed ID: 34854391
[TBL] [Abstract][Full Text] [Related]
16. Fracture Healing in Collagen-Related Preclinical Models of Osteogenesis Imperfecta.
Zieba J; Munivez E; Castellon A; Jiang MM; Dawson B; Ambrose CG; Lee B
J Bone Miner Res; 2020 Jun; 35(6):1132-1148. PubMed ID: 32053224
[TBL] [Abstract][Full Text] [Related]
17. A novel RNA-splicing mutation in COL1A1 gene causing osteogenesis imperfecta type I in a Chinese family.
Xia XY; Cui YX; Huang YF; Pan LJ; Yang B; Wang HY; Li XJ; Shi YC; Lu HY; Zhou YC
Clin Chim Acta; 2008 Dec; 398(1-2):148-51. PubMed ID: 18755172
[TBL] [Abstract][Full Text] [Related]
18. Scoliosis in osteogenesis imperfecta caused by COL1A1/COL1A2 mutations - genotype-phenotype correlations and effect of bisphosphonate treatment.
Sato A; Ouellet J; Muneta T; Glorieux FH; Rauch F
Bone; 2016 May; 86():53-7. PubMed ID: 26927310
[TBL] [Abstract][Full Text] [Related]
19. Lack of correlation between the type of COL1A1 or COL1A2 mutation and hearing loss in osteogenesis imperfecta patients.
Hartikka H; Kuurila K; Körkkö J; Kaitila I; Grénman R; Pynnönen S; Hyland JC; Ala-Kokko L
Hum Mutat; 2004 Aug; 24(2):147-54. PubMed ID: 15241796
[TBL] [Abstract][Full Text] [Related]
20. Mutations in type I collagen genes resulting in osteogenesis imperfecta in humans.
Gajko-Galicka A
Acta Biochim Pol; 2002; 49(2):433-41. PubMed ID: 12362985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
